BPTH Kacepetan wutah bathi saben saham ing taun lumaku Bio-Path Holdings, Inc

Bio-Path Holdings (BPTH) is optimizing the supply of RNA drugs through its network of plants to minimize synthesis disruptions. Anticipation of the results from mid-stage trials of liposomal agents against leukemias serves as the primary driver. The year-over-year percentage change in earnings per share demonstrates business resilience, where the value 99.70 represents the current metric. The company is also developing DNA therapy for targeted action on blood cancer genes.

BPTH - Wutah bathi ing taun lumaku Bio-Path Holdings Inc. ing rentang 04.07.2022 - 01.03.2025

Rincian analitis lan laporan data perusahaan Bio-Path Holdings (BPTH)

- nilai saham lan prakiraan konsensus rega:

Rega bursa Bio-Path Holdings Inc.|BPTH - Bagan rega target

- data kapitalisasi pasar:

Nilai pasar Bio-Path Holdings, Inc|BPTH - Nilai Perusahaan

- data ekuitas miturut neraca:

Ekuitas saben Saham Bio-Path Holdings|BPTH - Kapitalisasi Buku|Rasio Nilai Pasar marang Nilai Buku biopathholdings.com|BPTH - Total Aset Perusahaan

- indikator beban utang lan likuiditas:

Koefisien Total Utang marang Modal Bio-Path Holdings|BPTH - Utang jangka dawa marang ekuitas|Kewajiban jangka cendhak marang modal biopathholdings.com|BPTH - Gunggung utang perusahaan|Utang marang aset resik Bio-Path Holdings, Inc|BPTH - Utang jangka dawa perusahaan|Kewajiban jangka cendhak Bio-Path Holdings|Rasio cepet biopathholdings.com

- statistik bathi lan rasio pasar:

BPTH - Penghasilan resik|Bathi resik mangsa ngarep Bio-Path Holdings|BPTH - Pangali P/E|Pangali mangsa ngarep rega marang bathi Bio-Path Holdings, Inc|BPTH - Pangali rega marang bathi tumrap wutah|Nilai bisnis marang bathi operasional sadurunge panyusutan Bio-Path Holdings, Inc|BPTH - Bathi operasional EBITDA|Bathi saben saham sajroning taun lumaku Bio-Path Holdings|BPTH - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan biopathholdings.com|BPTH - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Bio-Path Holdings

Ringkesan analisis perusahaan:BPTH (Bio-Path Holdings Inc.)

This indicator reflects the year-over-year dynamics of net earnings per share, serving as an objective measure of cash flow generation efficiency. Analyzing year-over-year EPS growth rates allows for an assessment of the speed of capital recovery amid tight monetary policy. For Bio-Path Holdings (BPTH), this metric is critical as it reflects financial stability during the development of low-toxicity antisense drugs against leukemia.

Pesaing utama

Kacepetan wutah bathi saben saham ing taun lumaku TG Therapeutics Inc (TGTX)|Wutah bathi saben saham ing taun lumaku Arcellx Corp|Kacepetan wutah bathi saben saham ing taun lumaku Disc Medicine Pharma IRON|Wutah bathi ing taun lumaku SNDX|kuraoncology.com - Wutah bathi saben saham ing taun iki|Wutah bathi ing taun lumaku ADCT (ADC Therapeutics SA)|Foghorn Therapeutics, Inc. - Wutah bathi saben saham ing taun lumaku|Vor Bio - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun iki Nkarta, Inc. NKTX|coeptistx.com (COEP) - Wutah bathi saben saham ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku actiniumpharma.com (ATNM)|Wutah bathi resik saben saham ing taun iki ESLA|CASI - Owah-owahan bathi resik saben saham ing taun lumaku|Wutah bathi saben saham ing taun lumaku Marker Therapeutics (MRKR)|INAB: Dinamika bathi saben saham ing taun lumaku|Wutah bathi ing taun lumaku ERNA (Eterna Therapeutics Inc.)|Wutah bathi ing taun lumaku gtbiopharma.com GTBP|APTO: Wutah bathi resik saben saham ing taun iki|MEI Pharma Inc - Wutah bathi resik saben siji saham kanggo taun lumaku|VINC: Wutah bathi ing taun lumaku